Ignite Creation Date:
2024-05-05 @ 5:16 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00420056
Status:
COMPLETED
Last Update Posted:
2015-10-28
First Post:
2007-01-05
Brief Title:
An Investigational Study Drug Palbociclib PD-0332991 Is Being Studied In Patients With Mantle Cell Lymphoma Patients Must Have Received Prior Treatments For Mantle Cell Lymphoma
Sponsor:
Pfizer
Organization:
Pfizer
Study Overview
Official Title:
A Pilot Study Of Pd 0332991 In Patients With Previously Treated Mantle Cell Lymphoma
Status:
COMPLETED
Status Verified Date:
2015-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a pilot study evaluating tumor activity using Positron Emission Tomography which is also known as a PET scan This study will assess the safety of using PD-0332991 in patients with mantle cell lymphoma
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None